Go Deep
GeneDx Holdings Corp.
GeneDx Holdings Corp. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,738 | -17.9 | 7.93 | 0.69 | 6,186.38 |
| Oct 2026 | 17,407 | -18.9 | 8.38 | 0.69 | 6,514.35 |
| Oct 2026 | 17,262 | -18.3 | 8.57 | 0.69 | 6,668.16 |
| Oct 2026 | 17,860 | -17.5 | 7.77 | 0.69 | 6,024.82 |
| Oct 2026 | 17,617 | -18.3 | 8.10 | 0.69 | 6,285.38 |
| Oct 2026 | 17,396 | -18.9 | 8.39 | 0.69 | 6,517.68 |
| Oct 2026 | 17,377 | -19.0 | 8.42 | 0.69 | 6,520.49 |
| Oct 2026 | 17,540 | -18.5 | 8.20 | 0.69 | 6,337.40 |
| Oct 2026 | 18,536 | -15.5 | 6.86 | 0.69 | 5,322.02 |
GeneDx Holdings Corp. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 114,440,000.0 | 102,254,000.0 | 120,989,000.0 | 116,743,000.0 |
| Net Profit | -17,740,000.0 | -63,316,000.0 | -17,666,000.0 | -7,635,000.0 |
| EPS | -0.6 | -2.2 | — | -0.3 |
GeneDx Holdings Corp. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 427,539,000.0 | 305,450,000.0 | 202,566,000.0 | 234,694,000.0 | — |
| Net Profit | -21,021,000.0 | -52,286,000.0 | -175,767,000.0 | -548,980,000.0 | — |
| EPS | -0.7 | -1.9 | -7.2 | -53.8 | — |
GeneDx Holdings Corp. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 523,710,000.0 | 419,380,000.0 | 418,756,000.0 | 490,942,000.0 | — |
| Total Liabilities | 215,528,000.0 | 174,133,000.0 | 190,739,000.0 | 237,237,000.0 | — |
| Total Equity | 308,182,000.0 | 245,247,000.0 | 228,017,000.0 | 253,705,000.0 | — |
Owes vs Owns
GeneDx Holdings Corp. owed $0.49 for every $1 it owned in Jun 2026, up from $0.48 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.49× | 0.41× | 0.42× | 0.46× | 0.48× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
GeneDx Holdings Corp. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 32.7%Receivables 14.2%Inventory 2.7%Fixed assets (tangible) 13.2%Intangible assets 34.8%Other assets 2.5%
How it's funded — Dec 2025
Short-term debt 0.9%Long-term debt 9.2%Other liabilities 30.6%Shareholders' equity 58.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 171.3 | 141.2 | 130.1 | 123.9 |
| Receivables | 74.4 | 37.6 | 32.8 | 43.3 |
| Inventory | 14.0 | 10.7 | 8.8 | 13.7 |
| Fixed assets (tangible) | 69.1 | 58.5 | 59.4 | 84.3 |
| Intangible assets | 182.0 | 158.6 | 172.6 | 186.7 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 13.0 | 12.8 | 15.0 | 39.1 |
| Liabilities & equity | ||||
| Short-term debt | 4.5 | 1.2 | 0.5 | 4.8 |
| Long-term debt | 48.2 | 51.9 | 52.7 | 6.2 |
| Payables | 2.5 | 8.0 | 10.2 | 46.0 |
| Other liabilities | 160.3 | 113.1 | 127.3 | 180.2 |
| Shareholders' equity | 308.2 | 245.2 | 228.0 | 253.7 |
| Net tangible assets | 126.2 | 86.6 | 55.4 | 67.1 |
GeneDx Holdings Corp. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 33,279,000.0 | -28,496,000.0 | -180,147,000.0 | -319,155,000.0 | — |
| Investing Activities | -61,517,000.0 | -30,132,000.0 | -43,726,000.0 | -141,326,000.0 | — |
| Financing Activities | 48,025,000.0 | 44,162,000.0 | 186,238,000.0 | 197,315,000.0 | — |